Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in Nephron

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    August 2020
  1. WEN T, Zhang X, Wang Z, Zhou R, et al
    Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Patients with Renal Anemia: A Meta-Analysis of Randomized Trials.
    Nephron. 2020 Aug 31:1-11. doi: 10.1159/000508812.
    PubMed     Abstract available


    June 2020
  2. AKIZAWA T, Yamaguchi Y, Otsuka T, Reusch M, et al
    A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naive Chronic Kidney Disease Patients Not on Dialysis.
    Nephron. 2020 Jun 24:1-11. doi: 10.1159/000508100.
    PubMed     Abstract available


    January 2020
  3. ALFANDARY H, Rinat C, Gurevich E, Eisenstein I, et al
    Hemolytic Uremic Syndrome: A Contemporary Pediatric Experience.
    Nephron. 2020;144:109-117.
    PubMed     Abstract available


    August 2019
  4. AKIZAWA T, Macdougall IC, Berns JS, Yamamoto H, et al
    Iron Regulation by Molidustat, a Daily Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, in Patients with Chronic Kidney Disease.
    Nephron. 2019 Aug 6:1-12. doi: 10.1159/000502012.
    PubMed     Abstract available


    May 2019
  5. AKIZAWA T, Nangaku M, Yamaguchi T, Arai M, et al
    Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial.
    Nephron. 2019 May 22:1-9. doi: 10.1159/000500487.
    PubMed     Abstract available


    February 2019
  6. MATSUURA R, Doi K, Komaru Y, Miyamoto Y, et al
    Endogenous Erythropoietin and Hepatic Dysfunction in Acute Kidney Injury Requiring Renal Replacement Therapy.
    Nephron. 2019 Feb 1:1-7. doi: 10.1159/000496618.
    PubMed     Abstract available


    July 2018
  7. COZZOLINO M, Bolasco P, Ronco C, Conte G, et al
    Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE Study.
    Nephron. 2018 Jul 17:1-9. doi: 10.1159/000490769.
    PubMed     Abstract available


    June 2018
  8. FULLER DS, Robinson BM, Locatelli F, Pisoni RL, et al
    Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study.
    Nephron. 2018 Jun 26:1-7. doi: 10.1159/000490202.
    PubMed     Abstract available


    January 2018
  9. PYART R, Gilg J, Williams AJ
    Chapter 7 Haemoglobin, Ferritin and Erythropoietin in UK Adult Dialysis Patients in 2016: National and.
    Nephron. 2018;139 Suppl 1:165-190.
    PubMed    


    July 2017
  10. CARRARA C, Abbate M, Sabadini E, Remuzzi G, et al
    Acute Kidney Injury and Hemolytic Anemia Secondary to Mycoplasma pneumoniae Infection.
    Nephron. 2017 Jul 7. doi: 10.1159/000478991.
    PubMed     Abstract available


    January 2017
  11. FORD D, Gilg J, Williams AJ
    UK Renal Registry 19th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:165-188.
    PubMed    


    December 2016
  12. SASAKI S, Kawarazaki H, Hasegawa T, Shima H, et al
    Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause.
    Nephron. 2016.
    PubMed     Abstract available


    October 2016
  13. BORONAT M, Santana A, Bosch E, Lorenzo D, et al
    Relationship between Anemia and Serum Concentrations of Calcium and Phosphorus in Advanced Non-Dialysis-Dependent Chronic Kidney Disease.
    Nephron. 2016.
    PubMed     Abstract available


    April 2016
  14. ALBRIGHT RC JR, Dillon JJ, Hocum CL, Stubbs JR, et al
    Total Red Blood Cell Transfusions for Chronic Hemodialysis Patients in a Single Center, 2009-2013.
    Nephron. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: